2022 SPEAKERS
Farida Abane, Senior Medical Director, Pharmacovigilance, Deciphera Pharmaceuticals Llc
Adel Abou-Ali, Director, Risk Management & Benefit Risk, Global Pharmacovigilance, Astellas Pharma
Vivek Ahuja, Vice President, MACR & Global Head, Pharmacovigilance, Sun Pharmaceutical Industries Limited
Omar Aimer, Executive Committee member of ISoP; CEO and Founder, InnoVigilance
Wassim Aldairy, VP, Pharmacovigilance, Mersana Therapeutics, Inc.
Paridhi Anand, Associate Director, PV Operations, ICSR Quality and Analytics, Moderna Therapeutics
Jason Ancell, Director, Global Patient Safety, Gilead Sciences
Rawad Antoun, Director, Gcsp Regions Lead, Americas, CSL Behring
Dr Nicole Baker, Chief Executive Officer, biologit
Greg Ball, Head of Safety Statistics, Global Vaccine Safety, Novavax
Deepak Bandyopadhyay, Interim Director, Quality Analytics Data Sciences, BioResearch Quality & Compliance (BRQC), Jassen
Khaudeja Bano, Vice President, Combination Product Quality, Amgen
Victoria Bartasek, Senior Associate Director, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG
Melissa Bernal, Vice President, Asociación Colombiana de Farmacovigilancia
Arpita Bhowmick, Director, Global Omni Channel Contact Center Technology, Digital, Moderna
Kapil Bhutada, Director, PV Compliance and Training, Medicago
Benjamin Brown, Executive Director, American Society of Pharmacovigilance
Jim Buchanan, Clinician, Covilance
Siva Kumar Buddha, Global Pharmacovigilance Physician, Senior Manager, Teva Pharmaceuticals
Gloria Bustos, PhD in Pharmacy, Senior Director, Head of Pharmacovigilance, EMEA & APAC / Global Patient Safety, Baxter Healthcare
Anna Carina, Safety Compliance Principal Specialist, Novo Nordisk A/S
Mijal Chavda, Director, Global GxP Inspections & GVP Quality, Kyowa Kirin International
Michael Cheung, Senior Director, US REMS Strategy and Submissions Lead, Bristol Myers Squibb
David Chonzi, Global Head of PVE, Instil Bio
Edward Chow, Executive Director, Toxicology, AbbVie
Shaun Comfort, Principal Science Enablement Director, Genentech
Jacqueline Corrigan-Curay, Director, Office of Medical Policy, Center for Drug Evaluation and Research, FDA
Antonio Del Santo, Principal Medical Director Personalized Safety Interface Product Development Safety, Hoffmann La-Roche AG
Marc DeLuca, M.ENG HSE, US Risk Management Lead, Sanofi
Abhay Dhingra, Associate Director of Pharmacovigilance Digital Innovation, Moderna, Inc.
Christina Dickson, Head of Pharmacovigilance Operations, GSK
Steve Dingman, VP, Drug Safety and Pharmacovigilance, Alkermes
Nancy Dubois, Head of Global Patient Safety, EMD Serono
Helen Edelberg, MD, MPH, Deputy Director of Safety, Office of New Drugs, FDA
Kal Elhoregy, Director, Risk Evaluation and Mitigation Strategy (REMS), Amneal Pharmaceuticals
Joe Elicone, Global Head, Business Process, CSL Behring
Scott Fonseca, Vice President Pharmacovigilance and Regulatory Solutions, IQVIA
Jacqueline Gerena, Director, Program Management (REMS & RMP), Aimmune Therapeutics
Yvonne Gibble, Executive Director, Merck Sharp & Dohme LLC
Coryandar Gilvary, Chief Data Scientisit, OneThree Biotech
Michael Glaser, Safety Innovation Technology Director, GSK
Aaron Goodstein, Senior Director, Medical Safety Strategy and Operations, Johnson and Johnson Medical Devices
Kishore Gopu, Senior Director, REMS Operations, Teva Pharmaceuticals
Ruben Bonilla Guerrero, Chief Medical Officer, Innovative Gx Laboratories
Israel Gutierrez, VP, Drug Safety & Pharmacovigilance, Compugen Ltd
Bill Haddock, Head Of Safety, Ovid Therapeutics
Camilla Hammerum, Vice President, Global Patient Safety, Neuroscience Therapeutic Area Head, Ipsen
Rave Harpaz, Senior Director Research and Data Science, Oracle Health Sciences
Paul Hayashi, DILI Team Lead, Division of Hepatology & Nutrition, FDA
Barbara Hendrickson, Vice President, AbbVie
Alisa Hummings, Global Head, Medical Information, Local AE Intake, and CEVA Lifecycle Safety, IQVIA
Raúl J. Andrade, Professor of Medicine and Director, Department of Medicine, University of Malaga
Dutrochet Jacques Djoko, Senior Manager, Global Medical Reviewer, Sarepta Therapeutics
Kedar Joshi, Associate Vice President - Global Client Partner, Indegene, Inc.
Leandre Kenmogne Cheteu, R&D Researcher, Zhejiang Sci-Tech University
Jerry Kounga, Investigational Drug Lead Pharmacist, Ascension Health Wisconsin
Michael Kruczek, Director, Vault Safety, Veeva Systems
Dr. Graeme Ladds, Director of Pharmacovigilance & Chief Executive Officer, PharSafer
Claudia Lehmann, Head Global Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Mengchun Li, Pharmacovigilance Director, T.B. Alliance
David Lilienfeld, MD, Vice President, Drug Safety and Pharmacovigilance, Elevar Therapeutics
Bruno Mendez, VP, Global quality PV, Sanofi
Sherice Mills, Executive Director, Head of Risk Management – US & Canada, Jazz Pharmaceuticals
Ellen (Lena) Mishalov, Director, Pv Technological Innovations, Astellas Pharma
Andrew Mitchell, Senior Director, Pharmacovigilance & Regulatory Technology Solutions, IQVIA
Madhu Mondal, Senior Director, Safety Assessment, Cerevel Therapeutics
Andrew A. Monte, MD, PhD,, Professor of Emergency Medicine & Medical Toxicology, University of Colorado Hospital, Medical Director, Rocky Mountain Poison & Drug Safety Center (RMPDS)
Deanna Montes De Oca, Senior Director, PV Operations-Global Case Management, Moderna Therapeutics
Barbara Morollo, Executive Director and Head of Global Safety Science, Ultragenyx Pharmaceutical
Muhammad Ashar Naeem, Global Director, Head of Pharmacovigilance and Medical Affairs Department, Jamjoom Pharma
Jaylaxmi Nalawade, Associate Director - Pharmacovigilance and REMS, Lupin Inc.
Jaylaxmi Nalawade, Associate Director, Lupin Pharmaceuticals
Oyinkansola Odebo, Assistant Director Drug Safety, Supernus Pharmaceutical
Nneka Okere, Senior Director, Pharmacovigilance, Nurix Therapeutics
Bruce Palsulich, Vice President of Safety Product Strategy, Oracle Health Sciences
Badrish Patel, M.D., Vice President, Head of Safety, AlloVir
Vladimir Penkrat, Associate Vice President - Global Head of Safety & Regulatory Affairs, Indegene, Inc.
Sridevi Ponduru, Senior Medical Director, Global Patient Safety Evaluation, Takeda Pharmaceuticals USA Inc
Humaira Qureshi, CEO, Qinecsa Solutions
Sara Rogers,PharmD, BCPS, President, American Society of Pharmacovigilance
Maha Saad, Senior Director Drug Safety and Pharmacovigilance, Atara Biotherapeutics
Satya Sagi, Founder & Chief Executive Officer, Techsol Life Sciences
Milind Sardesai, Senior Director & Head, Pharmacovigilance, Covis Pharma
Dr. Linda J Scarazzini, Vice President, Pharmacovigilance & Patient Safety, AbbVie
Philip Schneider, Advisory Board Chair, Alliance for Safe Biologic Medicines
Vipin Sethi, Head Of Global Pharmacovigilance And Medical Affairs, Cadila Pharmaceuticals
Amgad Shebl, Senior Director, Global Safety Lead, Immunology, CSL Behring
Aarekh Shrestha, Head of Pharmacovigilance, Veranex
Prashant Sonar, Senior Manager, Pharmacovigilance Operations Compliance, Incyte Corp.
Mariette Boerstoel Streefland, Senior Vice President Patient Safety, Chief Safety Officer, AstraZeneca
Alan Summer, Vice President, Pharmacovigilance Services, Astrix Technology Inc
Marina Suvakov, Global Head Safety Surveillance, Philip Morris International
Tarak Thakker, Director, Safety Systems, BeiGene USA, Inc.
Siva Thiagarajan, Safety Practice Lead, ZS
Phil Tregunno, Head of Vigilance Operations, Medicines & Healthcare Products Regulatory Agency
Liliana Vargas Neri, Secretary of Executive Committee of Latin American Chapter, International Society of Pharmacovigilance
Dennis Vargo, Vice President, Head Of Drug Safety And Pharmacovigilance, Akebia Therapeutics , Inc.
Tina Veizovic, Senior Director, Global Patient Safety Business Strategy, Planning and Execution, BeiGene
Padma Vellanki, Director of Worldwide Patient Safety and Global Regulatory Data Analytics, Bristol-Myers Squibb
Ram Vempati, Head of Pharmacovigilance, Arcellx Inc
Deepa Venkataraman, Head of Global Patient Safety/PV and QA, Summit Therapeutics Inc
Michael von Forstner, Head of Clinical Safety and Pharmacovigilance, Biosimilars, Biogen
Marcin von Grotthuss, Principal Scientist, Investigative Toxicology, Takeda
Bianca Vora, Clinical Pharmacology Scientist, Genentech
Dany Ward, Senior Director, Clinical Safety and Risk Management, AlloVir
Max Waschbusch, TA Head Cardiovascular and Metabolism, CSL Behring
Susan Welsh MD, Senior Vice President, PV & Chief Safety Officer, Mirati Therapeutics
Richard Wolf, Executive Director, C.S.L. Behring Gmbh
Yuli Wu, Executive Director and Head of Drug Safety and Pharmacovigilance, Zai Lab
Andrew Yazwa, Risk Management Lead, Janssen
Syed Zaferuddin, Global Pharmacovigilance Manager and QPPV, Julphar
Patricia Zuluaga Arias, President, Asociación Colombiana de Farmacovigilancia
Get Involved At Drug Safety Congress Americas
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events